Advertisement
Merck & Co., Inc.

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

MRKNYSE
HealthcareDrug Manufacturers - General
$128.38
$2.93(2.34%)
U.S. Market opens in 43h 26m
Advertisement

Merck & Co., Inc. (MRK)

Meyka AI Score

Z

Key Financials

Market Cap317.1B
P/E Ratio35.69
EPS (TTM)$5.47
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$120.36
3 Months$117.74
1 Year Target$144.29

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $144.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.69 and a market capitalization of 317.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.34%
5-Day Change
12.64%
1-Month Change
7.23%
3-Month Change
7.95%
6-Month Change
20.23%
Year-to-Date (YTD) Change
21.96%
1-Year Change
62.86%
3-Year Change
13.53%
5-Year Change
67.03%
All-Time (Max) Change
32370.85%

Contact Information

908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

730,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions